Daniel E Ramos
CIK 1717317 · View on SEC EDGAR ↗
First SEC filing: Nov. 10, 2022 · Latest: Nov. 10, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2018 | COTY | P | 1,700 | $14.08 | $23,936 | 116,515 Direct | +1.48% | Acquired | -78.8% (price as of 2026-08-19) |
| May 14, 2018 | COTY | P | 25,000 | $14.38 | $359,500 | 114,815 Direct | +27.83% | Acquired | -79.3% (price as of 2026-08-19) |
| May 11, 2018 | COTY | P | 20,000 | $14.32 | $286,400 | 89,815 Direct | +28.65% | Acquired | -79.2% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 2, 2023 | MDLZ | Stock Options (right to buy) | Class A Common Stock (28,690) | $65.36 | March 2, 2033 | 28,690 | Acquired |
| Nov. 8, 2022 | MDLZ | Stock Options (right to buy) | Class A Common Stock (19,560) | $63.92 | Nov. 8, 2032 | 19,560 | Acquired |
| Nov. 14, 2019 | COTY | Restricted Stock Units | Class A common stock (88,888) | — | — | 88,888 | Acquired |
| Feb. 15, 2019 | COTY | Stock Option (right to buy) | Class A common stock (615,000) | $11.08 | Feb. 15, 2029 | 615,000 | Acquired |
| Sept. 4, 2018 | COTY | Restricted Stock Units | Class A common stock (46,985) | — | — | 46,985 | Acquired |
| Sept. 15, 2017 | COTY | Restricted Stock Units | Class A common stock (32,206) | — | — | 32,206 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
COTY
Chief Scientific Officer(10)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $425,599 | $1,000,000 | — | — | $134,400 | — | $8,694 | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.